Activating Cancer Communities Through an Exercise Strategy for Survivors
ACCESS
1 other identifier
interventional
100
1 country
1
Brief Summary
Cancer continues to have the dubious honor of being the leading cause of premature mortality in Canada. The good news is, advances in early detection and cancer treatments are extending the lives of those diagnosed with the disease. However, as more people are living longer, the impact of the therapies used to treat the disease are becoming increasingly apparent. Ranging from the physiological to psychological, cancer survivors are often confronted with substantial, disabling, and life-threatening consequences. The benefits of physical activity (all movement) and exercise more specifically have long been established as a means of prevention and treatment of chronic disease. Several recent reviews and meta-analyses have demonstrated that exercise is a safe and effective means of preventing and improving a multitude of physical and psychological treatment and disease-related sequelae across the cancer trajectory. For example, we know that cancer survivors who exercise not only have a reduced risk of disease recurrence and cancer mortality, but also have reduced acute/late effects of their cancer and/or its treatment such as anxiety, depression, and cancer-related pain. Regrettably, despite our substantial knowledge base, the majority of cancer survivors are not sufficiently active to realize these benefits over the long-term. Moreover, even with the development of evidence-based guidelines, exercise has not yet been widely implemented as a standard of care in the oncology setting largely due to a lack of resources, exercise expertise, and awareness of benefits. Continuing to provide cancer care with little guidance and understanding of the benefits of exercise places cancer survivors at an increased risk for recurrence, late effects, and/or onset of additional co-morbidities, and premature mortality. Therefore, it is important to consider best practices that will optimize and improve quality of survival. Building on the ongoing work of our Alberta-based colleagues and the Alberta Cancer Exercise (ACE) Program (an evidence-based clinic-to-community cancer exercise model), Activating Cancer Communities through an Exercise Strategy for Survivors (ACCESS) is designed to bridge the gap between research and practice and in doing so, lessen the impact of a cancer diagnosis and its treatment(s) on the physical and psychological well-being of cancer survivors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable cancer
Started Sep 2018
Longer than P75 for not_applicable cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 3, 2018
CompletedFirst Posted
Study publicly available on registry
July 26, 2018
CompletedStudy Start
First participant enrolled
September 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedFebruary 17, 2025
February 1, 2025
7.3 years
July 3, 2018
February 13, 2025
Conditions
Outcome Measures
Primary Outcomes (14)
Physiological Outcome - resting heart rate
Seated resting heart rate will be measured in beats per minute.
12 weeks
Physiological outcome - blood pressure
Seated systolic and diastolic blood pressure will be measured in mm of Hg
12 weeks
Physiological outcome - 6 minute walk test (6MWT)
The total distance walked in 6 minutes will be measured in meters
12 weeks
Physiological Outcome - handgrip
Handgrip will be measured in both the left and right hand. Two trials will be conducted on each side and the highest score will be used. Handgrip is measured in kg.
12 weeks
Physiological outcome - timed sit-to-stand
Time, is seconds, required to move from a seated to a standing position will be recorded.
12 weeks
Physiological Outcome - one legged stance/balance
Participants will be asked to stand on one leg with no support for as long as they can up to a maximum of 45 seconds. Trials will be conducted on the right and left side and time will be recorded in seconds.
12 weeks
Physiological Outcome - sit-and-reach
Hamstring flexibility will be measured in centimeters.
12 weeks
Physiological Outcome - shoulder flexibility
Shoulder flexibility will be measured in degrees
12 weeks
Daily steps
Total number of daily steps will be recorded using a pedometer.
12 weeks
Functional Assessment of Cancer therapy General (FACT-G)
The FACT-G is used to assess quality of life. It is a 27 item compilation of questions dived in four primary quality of life domains: 1) physical well-being; 2) social/family well-being; 3) emotional well-being; and 4) functional well-being.
12 weeks
Physical Activity Behaviour
The Godin Leisure Time Exercise Questionnaire will be used to assess physical activity and sedentary behaviour.
12 weeks
Sleep Quality
Sleep quality will be assessed using the Pittsburgh sleep quality index.
12 weeks
Depression Anxiety Stress Scales (DASS)
The depression anxiety stress scales consists of a list of 42 symptoms associated with depression, anxiety or stress. The participant is asked score the severity of the symptom over the past week on a 4 point scale.
12 weeks
Fatigue
The functional assessment of chronic illness therapy-fatigue (FACIT-F), which is a 13-item scale, will be used to assess participant levels of fatigue.
12-weeks
Study Arms (1)
ACCESS
EXPERIMENTALIndividuals that consent to the study will be assigned to a 12-week exercise program (ACCESS)
Interventions
Participants will complete a 12 week exercise session that will be comprised of aerobic and/or resistance and/or flexibility training.
Eligibility Criteria
You may qualify if:
- Have a diagnosis of cancer;
- Be 18+ years;
- Be pre-treatment, receiving active treatment, or have received cancer treatment within the past 5 years or have a late presenting/ongoing side-effects related to the cancer diagnosis;
- Be able to participate in mild levels of physical activity (at a minimum);
- Be willing to attend a 12-week exercise program in Halifax;
- Be able to provide informed written consent in English.
You may not qualify if:
- \- Less than 18 years of age.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
QEII Health Sciences Centre (Dickson Bldg)
Halifax, Nova Scotia, B3H 2Y9, Canada
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 3, 2018
First Posted
July 26, 2018
Study Start
September 1, 2018
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
February 17, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share